Key Development in Genomics Industry In November 2023, to stimulate research for infant genetic disease, Fabric Genomics teamed up with DNAnexus and Oxford Nanopore Technologies to develop CLIA/CAP-certified laboratories in neonatal intensive care units and pediatric intensive care units. By utilizing the new genomic sequencing platform by Oxford Nanopore, the team will enable genetic screening on newborns to identify rare infant genetic diseases quickly and accurately. The ultimate long-term objective of this program is to provide gene information promptly to enhance treatment and patient outcomes in critical care settings. The collaboration will improve early diagnosis and treatment of genetic disease in infants through optimizing genetic testing procedures and building additional diagnostic capacity for pediatric and neonatal intensive care unit clinicians using the combination of Fabric Genomics' cloud-based artificial intelligence platform and DNAnexus' cloud-based data platform. Read the Full Blog - https://www.coherentmarketinsights.com/blog/key-development-in-genomics-industry-1993